Search

John A. Ward

Examiner (ID: 10393)

Most Active Art Unit
2875
Art Unit(s)
2885, 2875
Total Applications
1293
Issued Applications
1015
Pending Applications
41
Abandoned Applications
239

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 827063 [patent_doc_number] => 07402729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => 'Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission' [patent_app_type] => utility [patent_app_number] => 11/151227 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15105 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402729.pdf [firstpage_image] =>[orig_patent_app_number] => 11151227 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/151227
Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission Jun 13, 2005 Issued
Array ( [id] => 4802596 [patent_doc_number] => 20080014183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Anticancer Agent Containing Dendritic Cell Having Rna Virus Transferred Thereinto' [patent_app_type] => utility [patent_app_number] => 11/630532 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 17547 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014183.pdf [firstpage_image] =>[orig_patent_app_number] => 11630532 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/630532
Anticancer agent containing dendritic cell having RNA virus transferred thereinto Apr 27, 2005 Issued
Array ( [id] => 6966010 [patent_doc_number] => 20050232907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Use of herpes vectors for tumor therapy' [patent_app_type] => utility [patent_app_number] => 11/097391 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9447 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232907.pdf [firstpage_image] =>[orig_patent_app_number] => 11097391 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/097391
Use of herpes vectors for tumor therapy Apr 3, 2005 Abandoned
Array ( [id] => 7004587 [patent_doc_number] => 20050169900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Allogeneic vaccine and methods to synthesize same' [patent_app_type] => utility [patent_app_number] => 11/096041 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 41465 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169900.pdf [firstpage_image] =>[orig_patent_app_number] => 11096041 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/096041
Allogeneic vaccine and methods to synthesize same Mar 30, 2005 Abandoned
Array ( [id] => 4739987 [patent_doc_number] => 20080233640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Prostate Stem Cell' [patent_app_type] => utility [patent_app_number] => 10/593128 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6580 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233640.pdf [firstpage_image] =>[orig_patent_app_number] => 10593128 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/593128
Prostate stem cell Mar 17, 2005 Issued
Array ( [id] => 6963061 [patent_doc_number] => 20050216964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Swine defective for transmission of porcine endogenous retrovirus and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/077996 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8917 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20050216964.pdf [firstpage_image] =>[orig_patent_app_number] => 11077996 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/077996
Swine defective for transmission of porcine endogenous retrovirus and uses thereof Mar 10, 2005 Abandoned
Array ( [id] => 7168234 [patent_doc_number] => 20050201985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Modified adenoviral vectors for use in vaccines and gene therapy' [patent_app_type] => utility [patent_app_number] => 11/064910 [patent_app_country] => US [patent_app_date] => 2005-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11981 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20050201985.pdf [firstpage_image] =>[orig_patent_app_number] => 11064910 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/064910
Modified adenoviral vectors for use in vaccines and gene therapy Feb 23, 2005 Abandoned
Array ( [id] => 5621491 [patent_doc_number] => 20060191026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Tissue specific expression of antibodies in chickens' [patent_app_type] => utility [patent_app_number] => 11/062325 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15986 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20060191026.pdf [firstpage_image] =>[orig_patent_app_number] => 11062325 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/062325
Tissue specific expression of antibodies in chickens Feb 17, 2005 Abandoned
Array ( [id] => 7168066 [patent_doc_number] => 20050201936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Models for viral-based cancer therapy' [patent_app_type] => utility [patent_app_number] => 11/057710 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26621 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20050201936.pdf [firstpage_image] =>[orig_patent_app_number] => 11057710 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/057710
Models for viral-based cancer therapy Feb 13, 2005 Abandoned
Array ( [id] => 7045116 [patent_doc_number] => 20050249711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Allogeneic vaccine and methods to synthesize same' [patent_app_type] => utility [patent_app_number] => 11/054300 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 41447 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249711.pdf [firstpage_image] =>[orig_patent_app_number] => 11054300 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/054300
Allogeneic vaccine and methods to synthesize same Feb 6, 2005 Abandoned
Array ( [id] => 5767893 [patent_doc_number] => 20060019387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Liver stem cell' [patent_app_type] => utility [patent_app_number] => 11/039119 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4776 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019387.pdf [firstpage_image] =>[orig_patent_app_number] => 11039119 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/039119
Liver stem cell Jan 18, 2005 Issued
Array ( [id] => 7005732 [patent_doc_number] => 20050171045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses' [patent_app_type] => utility [patent_app_number] => 11/025796 [patent_app_country] => US [patent_app_date] => 2004-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26866 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171045.pdf [firstpage_image] =>[orig_patent_app_number] => 11025796 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/025796
Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses Dec 28, 2004 Abandoned
Array ( [id] => 4652153 [patent_doc_number] => 20080039409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Method of Suppressing Cancer' [patent_app_type] => utility [patent_app_number] => 10/584289 [patent_app_country] => US [patent_app_date] => 2004-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7522 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20080039409.pdf [firstpage_image] =>[orig_patent_app_number] => 10584289 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/584289
Method of Suppressing Cancer Dec 23, 2004 Abandoned
Array ( [id] => 5535579 [patent_doc_number] => 20090235367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Non-human mammal comprising a modified SERCA2 gene and methods, cells, genes, and vectors thereof' [patent_app_type] => utility [patent_app_number] => 10/585077 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12019 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20090235367.pdf [firstpage_image] =>[orig_patent_app_number] => 10585077 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/585077
Non-human mammal comprising a modified SERCA2 gene and methods, cells, genes, and vectors thereof Dec 21, 2004 Abandoned
Array ( [id] => 7252969 [patent_doc_number] => 20050142659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Purified populations of stem cells' [patent_app_type] => utility [patent_app_number] => 11/015067 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9137 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142659.pdf [firstpage_image] =>[orig_patent_app_number] => 11015067 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/015067
Purified populations of stem cells Dec 15, 2004 Abandoned
Array ( [id] => 5795268 [patent_doc_number] => 20060015949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Transgenic non-human animals for producing heterologous and chimeric antibodies' [patent_app_type] => utility [patent_app_number] => 11/009840 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 102 [patent_figures_cnt] => 102 [patent_no_of_words] => 89179 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20060015949.pdf [firstpage_image] =>[orig_patent_app_number] => 11009840 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/009840
Transgenic non-human animals for producing heterologous and chimeric antibodies Dec 9, 2004 Abandoned
Array ( [id] => 5795276 [patent_doc_number] => 20060015957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Transgenic non-human animals for producing chimeric antibodies' [patent_app_type] => utility [patent_app_number] => 11/009873 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 102 [patent_figures_cnt] => 102 [patent_no_of_words] => 89232 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20060015957.pdf [firstpage_image] =>[orig_patent_app_number] => 11009873 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/009873
Transgenic non-human animals for producing chimeric antibodies Dec 9, 2004 Issued
Array ( [id] => 5822390 [patent_doc_number] => 20060026703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Transgenic non-human animals for producing heterologous and chimeric antibodies' [patent_app_type] => utility [patent_app_number] => 11/009769 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 102 [patent_figures_cnt] => 102 [patent_no_of_words] => 89236 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20060026703.pdf [firstpage_image] =>[orig_patent_app_number] => 11009769 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/009769
Transgenic non-human animals for producing heterologous and chimeric antibodies Dec 9, 2004 Abandoned
Array ( [id] => 7503587 [patent_doc_number] => 08034790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Use of MDA-7 to inhibit pathogenic infectious organisms' [patent_app_type] => utility [patent_app_number] => 11/001702 [patent_app_country] => US [patent_app_date] => 2004-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 29995 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034790.pdf [firstpage_image] =>[orig_patent_app_number] => 11001702 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/001702
Use of MDA-7 to inhibit pathogenic infectious organisms Nov 30, 2004 Issued
Array ( [id] => 5085390 [patent_doc_number] => 20070275441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Ocular Tissue Modification' [patent_app_type] => utility [patent_app_number] => 10/579995 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12566 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275441.pdf [firstpage_image] =>[orig_patent_app_number] => 10579995 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/579995
Ocular Tissue Modification Nov 18, 2004 Abandoned
Menu